COVID-19 Respiratory InfectionNCT07005908
Posture and Pain Measurements in Post-COVID-19
An observational study of COVID-19 Respiratory Infection, run by Izmir Democracy University at 1 site in Turkey (Türkiye).
Trial summary
In this study, it was aimed to reveal the results of posture measurement evaluated by artificial intelligence method, pain status and musculoskeletal disorders in individuals who have had COVID-19. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- COVID-19 Respiratory Infection
- What is being tested?
- Physical evaluations of post-COVID-19 individuals
- How many people
- 41 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2023to 1 Nov 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 41 individuals with post-COVID-19 were included in the research group.
Who may be able to join
- adult individuals aged 18 and over
- volunteering to participate in the study,
- Individuals who can understand and answer the questionnaires
- Individuals who were diagnosed with COVID-19 (individuals with a positive Polymerase Chain Reaction (PCR) test result, compatible with COVID-19 infection as a result of lung X-ray or lung tomography despite negative PCR test results) and discharged after recovery/home quarantine completed
Who cannot join
- Individuals with any physical or mental disability/disease and/or cognitive impairment
- Individuals newly diagnosed with COVID-19, therefore in quarantine at home or receiving treatment in hospital
- Individuals with suspected COVID-19
- Pregnant women
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Posture and Musculoskeletal System Disorders in Individuals Who Have Had COVID-19
In this study, it was aimed to reveal the results of posture measurement evaluated by artificial intelligence method, pain status and musculoskeletal disorders in individuals who have had COVID-19.
Read the detailed description
Thanks to artificial intelligence and machine learning technology, evaluations such as balance and foot pressure measurement can be made in patients today, as well as applications such as exercise and patient follow-up in rehabilitation, solutions to biomedical problems can be offered. Artificial intelligence and machine learning will continue to play an important role in education, training, patient care and research in the future. On the other hand, although various psychological and physical problems have been shown in individuals who have had COVID-19 during the prolonged COVID-19 pandemic process, musculoskeletal disorders and posture problems in these individuals remain unclear. For this reason, in this study, it was aimed to reveal the results of posture measurement evaluated by artificial intelligence method, pain status and musculoskeletal disorders in individuals who have had COVID-19.
- Conditions
- COVID-19 Respiratory Infection
- Being tested
- Physical evaluations of post-COVID-19 individuals
- Keywords
- pain, posture
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physical evaluations of post-COVID-19 individualsOther
In this study, pain, posture and musculoskeletal disorders were evaluated in post-COVID-19 individuals. The data to be obtained from all these evaluations were collected from the individuals at one time and over a period of approximately 1 hour at the most.
| Study group | Role | What they receive |
|---|---|---|
| Post-COVID-19 group | This group will consist of individuals who have had COVID-19. Receives: Other: Physical evaluations of post-COVID-19 individuals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Intensity
Pain intensity were measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).
Measured: through study completion, an average of 1 year
Secondary outcomes (2)
Posture assessment
Posture deviation were determined according to the deviation score in the joint centers obtained by photographing the posture of the individuals and uploading them to the system. Posture assessment were made with a mobile application based on the concept of postural analysis with artificial intelligence.
Measured: through study completion, an average of 1 year
Score of musculoskeletal disorders
The score of musculoskeletal disorders were evaluated using Cornell Musculoskeletal Disorders Questionnaire.A minimum of 0 and a maximum of 90 points are obtained from the scale for each body area. The total score is obtained by adding the scores for each body area. A high total score indicates that the discomfort in the musculoskeletal system is high.
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2025
- Study start1 Sep 2023
- Primary completion20 Dec 2023
- Study completion1 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for COVID-19 Respiratory InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 41 participants (actual)
Sponsor and investigators
- Lead sponsor
- Izmir Democracy University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gulsah Bargi, Izmir Democracy University
- Investigators
- GÜLŞAH BARĞI, Assoc. Dr., Study director, Izmir Democracy UniversityHELİN ÖNCEL, Principal investigator, Göztepe Sports ClubSİBEL DENİZ, Principal investigator, Izmir Democracy UniversitySARA MOHAMMADNEJADIAN, Principal investigator, Izmir Democracy UniversityMERVE NUR YÜKSEL, Principal investigator, Izmir Democracy University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07005908
- Sponsor's protocol ID
- Effects of COVID on posture
- Status last verified
- Jun 2025
- First submitted
- 4 Jun 2025
- Last updated
- 5 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Ahuja V, Nair LV. Artificial Intelligence and technology in COVID Era: A narrative review. J Anaesthesiol Clin Pharmacol. 2021 Jan-Mar;37(1):28-34. doi: 10.4103/joacp.JOACP_558_20. Epub 2021 Apr 10.
PubMed 34103818Itoh N, Mishima H, Yoshida Y, Yoshida M, Oka H, Matsudaira K. Evaluation of the Effect of Patient Education and Strengthening Exercise Therapy Using a Mobile Messaging App on Work Productivity in Japanese Patients With Chronic Low Back Pain: Open-Label, Randomized, Parallel-Group Trial. JMIR Mhealth Uhealth. 2022 May 16;10(5):e35867. doi: 10.2196/35867.
PubMed 35576560
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Posture and Musculoskeletal System Disorders in Individuals Who Have Had COVID-19
- ClinicalTrials.gov ID
- NCT07005908
- Acronym / sponsor ID
- Effects of COVID on posture
- Conditions
- COVID-19 Respiratory Infection
- Keywords
- pain, posture
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 41 participants (actual)
- Lead sponsor
- Izmir Democracy UniversityUniversity, hospital or other
- Study start
- 1 Sep 2023 (actual)
- Primary completion
- 20 Dec 2023 (actual)
- Study completion
- 1 Nov 2024 (actual)
- First posted
- 5 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, it was aimed to reveal the results of posture measurement evaluated by artificial intelligence method, pain status and musculoskeletal disorders in individuals who have had COVID-19.
Detailed description
Thanks to artificial intelligence and machine learning technology, evaluations such as balance and foot pressure measurement can be made in patients today, as well as applications such as exercise and patient follow-up in rehabilitation, solutions to biomedical problems can be offered. Artificial intelligence and machine learning will continue to play an important role in education, training, patient care and research in the future. On the other hand, although various psychological and physical problems have been shown in individuals who have had COVID-19 during the prolonged COVID-19 pandemic process, musculoskeletal disorders and posture problems in these individuals remain unclear. For this reason, in this study, it was aimed to reveal the results of posture measurement evaluated by artificial intelligence method, pain status and musculoskeletal disorders in individuals who have had COVID-19.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Post-COVID-19 group | – | Other: Physical evaluations of post-COVID-19 individualsThis group will consist of individuals who have had COVID-19. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 41 individuals with post-COVID-19 were included in the research group.
Key inclusion criteria (4 listed)
- adult individuals aged 18 and over
- volunteering to participate in the study,
- Individuals who can understand and answer the questionnaires
- Individuals who were diagnosed with COVID-19 (individuals with a positive Polymerase Chain Reaction (PCR) test result, compatible with COVID-19 infection as a result of lung X-ray or lung tomography despite negative PCR test results) and discharged after recovery/home quarantine completed
Key exclusion criteria (4 listed)
- Individuals with any physical or mental disability/disease and/or cognitive impairment
- Individuals newly diagnosed with COVID-19, therefore in quarantine at home or receiving treatment in hospital
- Individuals with suspected COVID-19
- Pregnant women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physical evaluations of post-COVID-19 individualsIn this study, pain, posture and musculoskeletal disorders were evaluated in post-COVID-19 individuals. The data to be obtained from all these evaluations were collected from the individuals at one time and over a period of approximately 1 hour at the most. | Other | Post-COVID-19 group |
Primary outcome
Pain Intensity
Time frame: through study completion, an average of 1 year
Pain intensity were measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).
2 secondary outcomes
Posture assessment
Time frame: through study completion, an average of 1 year
Score of musculoskeletal disorders
Time frame: through study completion, an average of 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2025.
- Background: PubMed 34103818Ahuja V, Nair LV. Artificial Intelligence and technology in COVID Era: A narrative review. J Anaesthesiol Clin Pharmacol. 2021 Jan-Mar;37(1):28-34. doi: 10.4103/joacp.JOACP_558_20. Epub 2021 Apr 10.
- Background: PubMed 35576560Itoh N, Mishima H, Yoshida Y, Yoshida M, Oka H, Matsudaira K. Evaluation of the Effect of Patient Education and Strengthening Exercise Therapy Using a Mobile Messaging App on Work Productivity in Japanese Patients With Chronic Low Back Pain: Open-Label, Randomized, Parallel-Group Trial. JMIR Mhealth Uhealth. 2022 May 16;10(5):e35867. doi: 10.2196/35867.
- Individual participant dataSharing planned: No
Related trials for COVID-19 Respiratory Infection
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
RecruitingObservational study
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Pneumonia, Community-Acquired, COVID-19 Pneumonia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
GÜLŞAH BARĞI, Assoc. Dr. study director
Izmir Democracy University
HELİN ÖNCEL principal investigator
Göztepe Sports Club
SİBEL DENİZ principal investigator
Izmir Democracy University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of COVID-19 Respiratory Infection, run by Izmir Democracy University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Intensity (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07005908, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.